🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial is studying the side effects and best dose of temsirolim...
Status
Completed
Location
Veteran's Administration Medical Center
Start Date
2008-12
Trial ID
NCT00693433
Treatments Being Tested
The investigators hypothesize that switching kidney transplant patients on ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02062892
Treatments Being Tested
This study was designed to compare 3 immunosuppression regimens: sirolimus ...
Status
Completed
Location
Hospital do Rim
Start Date
2017-06-18
Trial ID
NCT03468478
Treatments Being Tested
This research study is evaluating a drug called rapamycin as a possible tre...
Status
Completed
Location
Loma Linda University School of Medicine
Start Date
2005-12-20
Trial ID
NCT00126672
Treatments Being Tested
The restoration of endogenous insulin secretion carries significant hopes f...
Status
Completed
Location
University Hospital of Lille
Start Date
2003-05
Trial ID
NCT00446264
Treatments Being Tested
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
Central Hematology Oncology Medical Group, Inc.
Start Date
2009-09
Trial ID
NCT00985192
Treatments Being Tested
This phase I trial studies the side effects and the best dose of temsirolim...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2010-06
Trial ID
NCT01141244
Treatments Being Tested
Phase 1 trial to determine the safety, tolerability and maximum tolerated d...
Status
Completed
Location
Cancer Therapy and Research Center, University of Texas Health Center at San Antonio
Start Date
2003-05
Trial ID
NCT00060645
Treatments Being Tested
Background: Low-dose chemotherapy is easier for the body to tolerate than ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-03-01
Trial ID
NCT00923845